Lecture 3 - Complement Flashcards

1
Q

Complement: what is it, how many proteins are present, what does its activation do, and what does it do?

A

The major system of first-line, highly regulated humoral innate defence

> 50 proteins (soluble and membrane bound)

Triggers an amplifying cascade of sequential interactions - proteolytic cleavage and/or induced conformational changes causing enzyme activation, or a change in binding properties enabling progression to the next step

Products generated cause a range of effector functions and interface with both innate and adaptive immune responses:
* Inflammation
* Opsonisation/phagocytosis
* Cell lysis
* Control of adaptive responses
* Inflammasome activation
* Immune complex and apoptotic cell clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Complement components: where are they mainly sourced from, where else are they sourced from, how do they travel through the body, and how do they react to cytokines?

A

The main source of serum complement components is the liver (several are acute phase proteins)

Locally by other cells:
* Monocytes
* Macrophages
* DC
* Neutrophils
* Fibroblasts
* Epithelial cells (found in barrier secretions
* B and T cells
* Adipocytes

Circulate through the blood, waiting for activation

First-line defence, and also production are responsive to inflammatory cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complement components nomenclature

A

C = complement (numbered in the order they were discovered)

Alternative pathway (letters);
Factor B, Factor D, Properdin (Factor P)

Following Cleavage the
Smaller fragment = a (soluble), bigger fragment = b (binding)
EXCEPT C2, where C2a is bigger and C2b is smaller

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acute phase protein

A

Plasma proteins synthesised and secreted during the acute phase response, the complex series of changes occurring once infection is detected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Alternative, lectin, and classical pathways: what do they do, and how do they differ?

A

Result in the cleavage of C3 into C3a and C3b which have various effects that damage pathogens

  • Alternative - constantly active, keeps a low level of immune surveillance and helps other pathways generate a larger response
  • Lectin - activated in response to mannose-binding lectin
  • Classical - activated in response to pathogen binding/antibodies bound to pathogens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

C3 cleavage: what causes it to occur, what does it result in the production of, what enzyme catalyses it, and what does it do?

A

Activation of the classical, lectin, and/or alternative pathways

C3a and C3b

C3 convertase - C4bC2a complex

  • C3b energetically accommodates the loss of C3a and exposes highly reactive thioester which is attacked by neutrophilic groups, allowing attachment to local cell surfaces
  • Once C3b binds to the unwanted material, complement is activated and foreign material destruction occurs by a variety of mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

C3b: can it bind to healthy cells, what mechanisms exist to prevent healthy cell deaths, how is it regulated, and how long can it exist without binding?

A

Yes

Healthy cells have an inhibitory protein on their membrane that inactivates C3b

C3b amplification is inhibited on self-cells but in the absence of negative regulators, “turbo boosting” occurs and C3b levels are amplified

Undergoes spontaneous hydrolysis - prevents it from binding to its target site after it diffuses >40nm away from the convertase enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

C3b: once amplified and deposited, how does it further cause damage to unwanted cells?

A

C3b binds to membrane bound C3 convertases causing the, to change substrate preference - cleaving C5

  • C5 convertases cleave C5, forming C5b
  • C5b binds C6, C7, and C8
  • This complex binds many C9 molecules, forming the MAC
  • C9 deposition in the membrane eventually forms a pore
  • This pore causes loss of membrane integrity and cell lysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

C5 convertases: what are they and what do they do?

A

C4b2b3b and C3bBb3b

Cleaves C5, eventually forming the MAC downstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Classical and lectin pathways of complement activation: what are the molecules that detect pathogens, what is their structure, and what does their activation cause?

A

Classical - C1q, C1s, and C1r
Lectin - MBL/Ficolin, and MASP-2

  • Multichain structures
  • Bind through globular head regions
  • Cause activation of serine protease molecules associated with the stalk regions

Activation of complement - resulting in pathogen opsonisation/phagocytosis (iC3b), MAC formation (C5b6789), and inflammation (C3a and C5a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The classical pathway of complement activation: what is the process, what are the complement proteins involved and what do they do?

A

C1r binds pathogen, activates C1s, C1s cleaves C4 and C2, C4b opsonises pathogen and promotes C2 cleavage, C2a activates C3/C5 convertase, C3 promotes C5 cleavage and activates complement

  • C1q - Binds to pathogen, activation of C1r
  • C1r - Cleaves C1s into active form
  • C1s - Cleaves C4 and C2
  • C4a - Weak mediator of inflammation
  • C4b - Binds C2 for C1s cleavage, covalently binds pathogen and opsonises it
  • C2a - Cleaves C3 and C5
  • C2b - Precursor of vasoactive C2 kinin
  • C3a - Mediator of inflammation
  • C3b - Binds C5 for C2b cleavage, initiates amplification for the alternative pathway, many molecules of it bind to pathogen to opsonise it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lectin pathway of complement activation: what are the PRRs and what is the process?

A

MASP - MBL-associated serine protease
Ficolin - recognise carbohydrate moieties
MBL - mannose-binding lectin

  • MASP cleaves C4 into C4a and C4b
  • C4b opsonises pathogen and promotes C2 cleavage by MASP
  • C2a binds with C4b to form a C3 convertase (C4b2a)
  • C3 convertase cleaves C3 into C3a and C3b
  • C3a promotes inflammation
  • C3b binds with C3 convertases (C3bBb and C4b2a) and forms C5 convertases
  • C5 convertases cleave C5 and activates complement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alternative pathway of complement activation: what is the point of it, how does it interact with the other pathways, and how does it work?

A

Provides immune surveillance and a standard baseline C3b level in the body

Amplifies C3b deposition from other pathways (can also be for itself too) - C3bBb produced can cleave more C3 which can then form more C3bBb (amplifiication results in 80-90% of generated C3b)

  • C3 may be spontaneously hydrolysed by water, forming iC3/C3(H₂O)
  • C3(H₂O) allows binding of Factor B
  • Circulating C3(H₂O)B can bind Factor D
  • Activated Factor D cleaves Factor B then dissociates
  • Fluid phase C3(H₂O)Bb can act as a C3 convertase, cleaving soluble C3 into C3a+C3b
  • Indiscriminate C3b binding occurs (healthy self-cells have mechanisms to deactivate it)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

C1q: what does it do, how does it do it, what types of functions can it have, and how do each of them work?

A

Recognises charged patterns using Ca²⁺ dependent binding (>100 targets described)

Direct binding to PAMPS/DAMPS:
* Pathogens - LPS, bacterial porins
* Apoptotic cells - phosphatidyl serine, dsDNA, GAPDH, annexins, calreticulin

Indirect binding:
* Antigen-bound IgM (planar to staple confirmation on binding antigen)
* IgG isotypes (IgG1, IgG3) clustered in immune complexes (nb natural abs tend to be polyreactive)
* Surface-bound pentraxins eg C-reactive protein, PTX-3 (TSG-14)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

C1q indirect binding: How is it ensured only to activate complement on desired cells?

A

The linker molecule provides targeting/discrimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FP: what is it, what does it do, how is it produced, what pathways does it interact with, and does it have any other effects?

A

Properdin

Positive regulator of alternative pathway activation

Stored in granules inside neutrophils to respond to infection (C5a) and form a positive feedback loop

Binds to C3bBb and stabilising it, turning its normal half life (T ~90s) and making it last ~5-10x longer for it to exact its effect

May act as a PRR:
* Reported to bind to certain bacteria and certain apoptotic cells, acting as a platform for C3b or C3(H₂O) and Factor B, supporting C3bBb generation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

iC3b: what is it, what does it do, how is it formed, why is it necessary

A

Inactivated C3b

Restricts further amplification but leaves the target tagged (for opsonisation) - limits the immune response to prevent too much damage

Cleaving C3b by Factor I and cofactors (Factor H, etc)

C3b has to be turned off

18
Q

Regulators of the CLA complement pathways: what are they and what do they do?

A

All act by either dissociating C3 convertase or promoting Factor I-induced degradation (cofactors)

  • FHRs - Factor-H related proteins, form iC3b (FH/FHL-1, MCP, CR1, etc)
  • Properdin - stabilises C3bBb
  • Factor I - cleaves C3b into iC3b
  • Factor H - binds C3b, displacing Bb (cofactor for Factor I)
  • C1inh - inhibits C1 (removing C1r and C1s) activated MASP-2 (removing it from MBL)
  • DAF - CD55, displaces Bb from C2a and C3b, accelerating the decay of C3 and C5 convertases
  • MCP - CD46, promotes C3b and C4b inactivation by Factor I (cofactor for Factor I)
  • CR1 - CD35, binds C4b/C3b, displacing C2a or Bb, a cofactor for Factor I, accelerating the decay of C3 and C5 convertases
  • C4BP - binds C4b/C3b, displacing C2a or Bb, cofactor for Factor I, accelerating the decay of C3 and C5 convertases
  • Clusterin/vitronectin - Clear soluble C5b67 trimer, preventing binding to membrane-bound C8
  • Protectin - CD59, prevents MAC formation on autologous/allogeneic cells (widely expressed on membranes)
19
Q

Factor H: how does it only negatively regulate self-cells?

A

Preferably associates with self-cells through self-associated molecular patterns - glycosaminoglycans and sialylated glycans

20
Q

Allogeneic and autologous cells: what does it mean?

A

Allogeneic - same species (but different individual)

Autologous - individuals “self” cells

21
Q

MAC: what is it, what are its components, what does it do, does it destroy all cells, and what other functions may it have?

A

The membrane attack complex, formed from C5b678 and C9, with C9 molecules forming the pore

Forms a pore in the cell that results in ion imbalance and osmotic lysis

No, some cells are naturally resistant, by having thick cell walls for example

Inflammasome activation - transient lesions may be made in healthy cells due to MAC, causing ion imbalances, signalling to TLRs and stimulating inflammasome activation and proinflammatory cytokine IL-1β

22
Q

CD59: what is it, what does it do, and how does it do its function?

A

Protectin - prevents MAC formation

Prevents the unfolding of C9 which is what allows it to join the C5b678 complex to form the MAC

23
Q

Anaphylatoxins: what are they, what are some examples, what do they do?

A

Inducers of inflammation

C3a and C5a (C5a has stronger activity)

  • Vascular changes - increased permeability and changes in adhesion molecules
  • Recruitment of macrophages, Polymorphonuclear leukocytes (PMN) and lymphocytes
  • Activation of mast cells to release other inflammatory mediators such as histamine
  • Cross-talk with TLRs and other receptors (eg enhanced phagocytic uptake)
  • Increased fluid in tissues hastens movement of pathogen bearing APC and opsonised material to local lymph nodes to recruit adaptive immunity
24
Q

Polymorphonuclear leukocytes: what are they what are some examples, and what part of the immune system are they a part of?

A

Granulocytes

  • Neutrophils
  • Basophils
  • Eosinophils
  • Monocytes

Innate immune system

25
Q

Opsonisation: what is it and what is it used for?

A

Target and coat cells unwanted in the body (pathogens, apoptotic cells, etc) for removal

  • Pathogen elimination - first-line defence
  • Clearance of immune complexes
  • Homeostatic apoptotic cell removal
26
Q

CR proteins: what are they, what are the types, what do they bind, what do they do, and what cells are they found in?

A

Complement receptor proteins

  • CR1 (CD35) - C3b/C4bi - promotes C3b and C4b decay, stimulates phagocytosis (requires C5a), erythrocyte transport of immune complexes - erythrocytes, macrophages, monocytes, PMN leukocytes, B cells, FDC
  • CR2 (CD21) - C3d/iC3b/C3dg - part of B-cell co-receptor, enhances B-cell response to antigens bearing C3d/iC3b/C3dg Epstein-barr virus receptor - B cells, FDC
  • CR3 (CD11b:CD18 heterodimer/Mac-1) - iC3b - stimulates phagocytes - macrophages, monocytes, PMN leukocytes, FDC
  • CR4 (CD11c:CD18 heterodimer/gp150, gp95) - iC3b - stimulates phagocytes - macrophages, monocytes, PMN leukocytes, dendritic cells
  • CRIg - C3b/iC3b - phagocytosis of circulating pathogens - tissue-resident macrophages, hepatic sinusoid macrophages
27
Q

CR1: what is it, what is it a receptor for, what does it do, what cell types is it found in, and what is it also?

A

Complement receptor 1 - CD35

C3b/C4bi

  • Promotes C3b and C4b decay
  • Stimulates phagocytosis (requires C5a)
  • Erythrocyte transport of immune complexes

Erythrocytes, macrophages, monocytes, PMN leukocytes, B cells, FDC

a CCP domain

28
Q

CR2: what is it, what is it a receptor for, what does it do, what cell types is it found in, and what is it also?

A

Complement receptor 2 - CD21

C3d/iC3b/C3dg

  • Part of B-cell co-receptor
  • Enhances B-cell response to antigens bearing C3d/iC3b/C3dg Epstein-Barr virus receptor

B cells and FDC

a CCP domain

29
Q

CR3: what is it, what is it a receptor for, what does it do, what cell types is it found in, and what is it also?

A

Complement receptor 3 - (CD11b:CD18 heterodimer/Mac-1)

iC3b

  • Stimulates phagocytes

Macrophages, monocytes, PMN leukocytes, and FDC

An integrin (β2 integrin)

30
Q

CR4: what is it, what is it a receptor for, what does it do, what cell types is it found in, and what is it also?

A

Complement receptor 4 - CD11c:CD18 heterodimer/gp150, gp95

iC3b

  • Stimulates phagocytes

Macrophages, monocytes, PMN leukocytes, and dendritic cells

An integrin (β2 integrin)

31
Q

CRIg: what is it, what is it a receptor for, what does it do, what cell types is it found in, and what is it also?

A

Immunoglobulin complement receptor

C3b/iC3b

  • Phagocytosis of circulating pathogens

Tissue-resident macrophages and hepatic sinusoid macrophages

Ig domain

32
Q

Inflammation: what is its role in phagocytosis?

A

Phagocytic uptake of opsonised material by complement receptors is promoted within the context of an ongoing inflammatory response (ie CR1 stimulates phagocytosis but only in the presence of C5a)

33
Q

SLE

A

ER

34
Q

Apoptotic cells: how are they formed?

A

Apoptotic cells must be different to healthy cells to prevent autoimmunity

Apoptotic cells undergo cell modifications:
* Reveal DAMPs (eg PS, dsDNA, calreticulin)
* Decrease expression of some complement regulatory receptors (eg MCP)
* Opsonisation by C1q and iC3b

These modifications result in the cell being easily identified as not healthy and needing to be removed

35
Q

Apoptotic cell destruction: how do phagocytes know what the apoptotic cells are, what does their detection result in, what changes in the surroundings occur, and why?

A

C1q and iC3b tags

Tolerogenic responses:
* Increase in inhibitory and decrease in co-stimulatory molecules on DC and macrophages
* Production of anti-inflammatory cytokines
* Impaired maturation of DC and induction of Tregs

DAMPs released by apoptotic cells may also trigger inflammatory responses - not ideal as unnecessary inflammation isn’t good, ensures inflammation is only triggered when necessary

36
Q

Complement proteins: how do they interact with t-cells?

A

Indirect effect:
* Influence maturation and function of APCs - cross-talk of anaphylatoxins and TLRs modulating maturation and polarising cytokine production

Direct actions via complement receptors on T cells (local action of complement fragments generated intracellularly in T cells in a convertase-independent manner):
* Regulates resting T cell survival
* Influencing polarisation and resolution of T-cell responses

37
Q

Local complement protein generation (ER)

A

There is a new appreciation that locally generated intracellular complement can cross-talk with pathways of cell physiology to influence local immune responses

38
Q

Complement proteins: what are they and what do they do?

A
  • C1q - Binds to pathogen, activation of C1r
  • C1r - Cleaves C1s into active form
  • C1s - Cleaves C4 and C2
  • C4a - Weak mediator of inflammation
  • C4b - Binds C2 for C1s cleavage, covalently binds pathogen and opsonises it
  • C2a - Cleaves C3 and C5
  • C2b - Precursor of vasoactive C2 kinin
  • C3a - Promotes inflammation
  • C3b - Binds C5 for C2b cleavage, initiates amplification for the alternative pathway, many molecules of it bind to pathogen to opsonise it
  • C4b2a - C3 convertase, cleaves C3 into C3a and C3b
  • C3bBb - C3 convertase, cleaves C3 into C3a and C3b
  • C4b2a3b - C5 convertase, cleaves C5 into C5a and C5b
  • C3bBb3b - C5 convertase, cleaves C5 into C5a and C5b
  • C5a - Promotes inflammation
  • C5b - forms a trimer with C6/C7
  • C5b67 - binds C8
  • C5b678 - binds C9 molecules and forms the membrane attack complex
39
Q

The classical pathway of complement activation: what is the initial serine protease, what is the protein that covalently binds to the surface, what is the C3/C5 convertase, what regulators control the action, what molecule causes opsonisation, what molecule triggers an effector function pathway, what molecules cause local inflammation, and are there any positive regulators?

A

C1q

C4b

C3 - C4b2a
C5 - C4b2a3b

CR1 and C4BP

C3b

C5b

C3a and C5a (C5a is stronger inflammatory agent than C3a)

No

40
Q

The classical pathway of complement activation: what is the initial serine protease, what is the protein that covalently binds to the surface, what is the C3/C5 convertase, what regulators control the action, what molecule causes opsonisation, what molecule triggers an effector function pathway, what molecules cause local inflammation, and are there any positive regulators?

A

MASP-2

C4b

C3 - C4b2a
C5 - C4b2a3b

CR1 and C4BP

C3b

C5b

C3a and C5a (C5a is stronger inflammatory agent than C3a)

No

41
Q

The alternative pathway of complement activation: what is the initial serine protease, what is the protein that covalently binds to the surface, what is the C3/C5 convertase, what regulators control the action, what molecule causes opsonisation, what molecule triggers an effector function pathway, what molecules cause local inflammation, and are there any positive regulators?

A

Factor D

Bb (B subunit of Factor B)

C3 - C3bBb
C5 - C3bBb3b

CR1 and Factor H

C3b

C5b

C3a and C5a (C5a is stronger inflammatory agent than C3a)

Yes, properdin